Genetic evaluation and counseling for epilepsy

Nature Reviews Neurology

Volumn 6, Issue 8, 2010, Pages 445-453

  Pal, Deb K ^a   Pong, Amanda W ^b   Chung, Wendy K ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Division of Pediatric Epilepsy   (United Kingdom)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE LIKE 5; FILAMIN A; SODIUM CHANNEL NAV1.1; UNCLASSIFIED DRUG;

CLINICAL EVALUATION; CORTICAL DYSPLASIA; DNA SEQUENCE; DRAVET SYNDROME; EPILEPSY; FACE DYSMORPHIA; FEBRILE CONVULSION; GENE DELETION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; IDIOPATHIC DISEASE; INFANTILE SPASM; MENTAL DEFICIENCY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT PLANNING;

EPILEPSY; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS;

EID: 77956263092     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.92     Document Type: Review

References (93)

1. Reid, C. A., Berkovic, S. F. & Petrou, S. Mechanisms of human inherited epilepsies. Prog. Neurobiol. 87, 41-57 (2009).
2. Pal, D. K., Strug, L. J. & Greenberg, D. A. Evaluating candidate genes in common epilepsies and the nature of evidence. Epilepsia 49, 386-392 (2007).
3. Greenberg, D. A. & Pal, D. K. The state of the art in the genetic analysis of the epilepsies. Curr. Neurol. Neurosci. Rep. 7, 320-328 (2007).
4. Deprez, L., Jansen, A. & De Jonghe, P. Genetics of epilepsy syndromes starting in the first year of life. Neurology 72, 273-281 (2009).
5. Kim, H. S. et al. Altered DNA copy number in patients with different seizure disorder type: by array-CGH. Brain Dev. 29, 639-643 (2007).
6. Dibbens, L. M. et al. Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. Hum. Mol. Genet. 18, 3626-3631 (2009).
7. GeneTests at NCBI. GeneTests [online]. http://www.genetests.org/(2010).
8. The portal for rare diseases and orphan drugs. Orphanet [online]. http://www.orpha.net (2010).
9. Scheffer, I. E., Zhang, Y. H., Jansen, F. E. & Dibbens, L. Dravet syndrome or genetic (generalized) epilepsy with febrile seizures plus? Brain Dev. 31, 394-400 (2009).
10. Hattori, J. et al. A screening test for the prediction of Dravet syndrome before one year of age. Epilepsia 49, 626-633 (2008).
11. Marini, C. et al. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia 50, 1670-1678 (2009).
12. Sijben, A. E. et al. Does a SCN1A gene mutation confer earlier age of onset of febrile seizures in GEFS+? Epilepsia 50, 953-956 (2009).
13. Singh, N. A. et al. A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome. PLoS Genet. 5, e1000649 (2009).
14. Meisler, M. H., O'Brien, J. E. & Sharkey, L. M. The sodium channel gene family: epilepsy mutations, gene interactions and modifier effects. J. Physiol. 588, 1841-1848 (2010).
15. Depienne, C. et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet. 5, e1000381 (2009).
16. Kassai, B. et al. Severe myoclonic epilepsy in infancy: a systematic review and a meta-analysis of individual patient data. Epilepsia 49, 343-348 (2008).
17. Striano, P. et al. An open-label trial of levetiracetam in severe myoclonic epilepsy of infancy. Neurology 69, 250-254 (2007).
18. Caraballo, R. H. et al. Ketogenic diet in patients with Dravet syndrome. Epilepsia 46, 1539-1544 (2005).
19. Delgado-Escueta, A. V. & Bourgeois, B. F. Debate: does genetic information in humans help us treat patients? PRO\genetic information in humans helps us treat patients. CON\genetic information does not help at all. Epilepsia 49 (Suppl. 9), 13-24 (2008).
20. Guerrini, R., Belmonte, A. & Genton, P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 39, 2-9 (1998).
21. Miller, I. O. & Sotero De Menzies, M. A. SCN1A-related seizure disorders. GENEReviews [online], http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi- book=gene&part=gefs (2007).
22. Scheffer, I. E. & Berkovic, S. F. Generalised epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120, 479-490 (1997).
23. +): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations. Epilepsia 45, 149-158 (2004).
24. Marini, C. et al. Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities. Epilepsia 48, 1678-1685 (2007).
25. A receptor dysfunction in epilepsy: a mutation in the γ2-subunit gene. Nat. Genet. 28, 46-48 (2001).
26. Kang, J. Q., Shen, W. & Macdonald, R. L. The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression. J. Neurosci. 29, 2845-2856 (2009).
27. + channel β1 subunit gene SCN1B. Nat. Genet. 19, 366-370 (1998).
28. Frost, J. D. & Hrachovy, R. A. In Infantile Spasms: Diagnosis, Management and Prognosis (Kluwer Academic Publishers, Norwell, 2003).
29. Marshall, C. R. et al. Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11. Am. J. Hum. Genet. 83, 106-111 (2008).
30. Stromme, P. et al. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat. Genet. 30, 441-445 (2002).
31. Weaving, L. S. et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am. J. Hum. Genet. 75, 1079-1093 (2004).
32. Mills, P. B. et al. Mutations in antiquitin in individuals with pyridoxine-dependent seizures. Nat. Med. 12, 307-309 (2006).
33. Gallagher, R. C. et al. Folinic acid-responsive seizures are identical to pyridoxine-dependent epilepsy. Ann. Neurol. 65, 550-556 (2009).
34. Chiron, C., Dumas, C., Jambaqué, I., Mumford, J. & Dulac, O. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res. 26, 389-395 (1997).
35. Elterman, R. D., Shields, W. D., Mansfield, K. A. & Nakagawa, J. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 57, 1416-1421 (2001).
36. Lacy, J. R. & Penry, J. K. In Infantile Spasms (Raven Press, New York, 1976).
37. Matsumoto, A. et al. Infantile spasms: etiological factors, clinical aspects, and long term prognosis in 200 cases. Eur. J. Pediatr. 135, 239-244 (1981).
38. Guerrini, R. & Marini, C. Genetic malformations of cortical development. Exp. Brain Res. 173, 322-333 (2006).
39. Fox, J. W. et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 21, 1315-1325 (1998).
40. Sheen, V. L. et al. Autosomal recessive form of periventricular heterotopia. Neurology 60, 1108-1112 (2003).
41. Fink, J. M., Dobyns, W. B., Guerrini, R. & Hirsch, B. A. Identification of a duplication of Xq28 associated with bilateral periventricular nodular heterotopia. Am. J. Hum. Genet. 61, 379-387 (1997).
42. Sicca, F., Silengo, M., Parrini, E., Ferrero, G. B. & Guerrini, R. Subcortical band heterotopia with simplified gyral pattern and syndactyly. Am. J. Med. Genet. A 119A, 207-210 (2003).
43. Gleeson, J. G. et al. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 92, 63-72 (1998).
44. Des Portes, V. et al. A novel CNS gene required for neuronal migration and involved in X-linked subcortical laminar heterotopia and lissencephaly syndrome. Cell 92, 51-61 (1998).
45. Hong, S. E. et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat. Genet. 26, 93-96 (2000).
46. Kitamura, K. et al. Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat. Genet. 32, 359-369 (2002).
47. Bingham, P. M., Lynch, D., McDonald-McGinn, D. & Zackai, E. Polymicrogyria in chromosome 22 delection syndrome. Neurology 51, 1500-1502 (1998).
48. Roll, P. et al. SRPX2 mutations in disorders of language cortex and cognition. Hum. Mol. Genet. 15, 1195-1207 (2006).
49. Cunniff, C. Prenatal screening and diagnosis for pediatricians. Pediatrics 114, 889-894 (2004).
50. Singh, R., Gardner, R. J., Crossland, K. M., Scheffer, I. E. & Berkovic, S. F. Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters. Epilepsia 43, 127-140 (2002).
51. Inoue, Y. et al. Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 120, 939-953 (1997).
52. Battaglia, A. & Guerrini, R. Chromosomal disorders associated with epilepsy. Epileptic Disord. 7, 181-192 (2005).
53. Schinzel, A. & Niedrist, D. Chromosome imbalances associated with epilepsy. Am. J. Med. Genet. 106, 119-124 (2001).
54. Macleod, S. et al. Electro-clinical phenotypes of chromosome disorders associated with epilepsy in the absence of dysmorphism. Brain Dev. 27, 118-124 (2005).
55. Biervert, C. et al. A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406 (1998).
56. Singh, N. A. et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18, 25-29 (1998).
57. Steinlein, O. K. et al. A missense mutation in the neuronal nicotinic receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11, 201-203 (1995).
58. Kalachikov, S. et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet. 30, 335-341 (2002).
59. Grill, M. F., Losey, T. E. & Ng, Y. T. The Hitchhiker's guide to the child neurologist's genetic evaluation of epilepsy. Semin. Pediatr. Neurol. 15, 32-40 (2008).
60. Ferraro, T. N., Dlugos, D. J. & Buono, R. J. Role of genetics in the diagnosis and treatment of epilepsy. Expert Rev. Neurother. 6, 1789-1800 (2006).
61. Helbig, I., Scheffer, I. E., Mulley, J. C. & Berkovic, S. F. Navigating the channels and beyond: unravelling the genetics of the epilepsies. Lancet Neurol. 7, 231-245 (2008).
62. Blandfort, M., Tsuboi, T. & Vogel, F. Genetic counseling in the epilepsies. I. Genetic risks. Hum. Genet. 76, 303-331 (1987).
63. Scheffer, I. E. et al. Autosomal dominant rolandic epilepsy and speech dyspraxia: a new syndrome with anticipation. Ann. Neurol. 38, 633-642 (1995).
64. Kugler, S. L. et al. An autosomal dominant genetically heterogeneous variant of rolandic epilepsy and speech disorder. Epilepsia 49, 1086-1090 (2008).
65. Guerrini, R. et al. Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: delineation of the syndrome and gene mapping to chromosome 16p12-112. Ann. Neurol. 45, 344-352 (1999).
66. Clarke, T. et al. High risk of reading disability and speech sound disorder in rolandic epilepsy families: case-control study. Epilepsia 48, 2258-2265 (2007).
67. Clarke, T., Baskurt, Z., Strug, L. J. & Pal, D. K. Shared genetic risk factors for migraine and rolandic epilepsy: family case-control study. Epilepsia 50, 2428-2433 (2009).
68. Heijbel, J., Blom, S. & Rasmuson, M. Benign epilepsy of childhood with centrotemporal EEG foci: a genetic study. Epilepsia 16, 285-293 (1975).
69. Bali, B. et al. Autosomal dominant inheritance of centrotemporal sharp waves in rolandic epilepsy families. Epilepsia 48, 2266-2272 (2007).
70. Tsuboi, T. & Christian, W. On the genetics of primary generalized epilepsy with sporadic myoclonias of impulsive petit mal. A clinical and electroencephalographic study of 399 probands. Humangenetik 19, 155-182 (1973).
71. Janz, D., Beck-Mannagetta, G. & Pantazis, G. In Genetics of the Epilepsies (eds Beck-Mannagetta, G., Anderson, V. E. & Janz, D.) 43-66 (Springer-Verlag, Berlin, 1989).
72. Genton, P., Gelisse, P. & Thomas, P. In Juvenile Myoclonic Epilepsy\the Janz Syndrome Ch. 2 (eds Schmitz, B. & Sander, T.) 12-32 (Wright Biomedical Publishing, Petersfield, 2000).
73. Pal, D. K. et al. Complex inheritance and parent-of-origin effect in juvenile myoclonic epilepsy. Brain Dev. 28, 92-98 (2006).
74. Tsuboi, T. & Endo, S. Incidence of seizures and EEG abnormalities among offspring of epileptic patients. Hum. Genet. 36, 173-189 (1977).
75. Beck-Mannagetta, G., Janz, D., Hoffmeister, U., Behl, I. & Scholz, G. In Genetics of the Epilepsies Ch. 15 (eds Beck-Mannagetta, G., Anderson, V. E., Doose, H. & Janz, D.) 119-126 (Springer-Verlag, Berlin, 1989).
76. Durner, M. et al. Genome scan of idiopathic generalised epilepsy: evidence for major susceptibility gene and modifying genes influencing the seizure type. Ann. Neurol. 49, 328-335 (2001).
77. Greenberg, D. A. et al. Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am. J. Med. Genet. 31, 185-192 (1988).
78. Greenberg, D. A. et al. Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association and maternal inheritance in juvenile myoclonic epilepsy. Am. J. Hum. Genet. 66, 508-516 (2000).
79. Weissbecker, K. A. et al. Confirmation of linkage between juvenile myoclonic epilepsy locus and the HLA region of chromosome 6. Am. J. Med. Genet. 38, 32-36 (1991).
80. Sander, T. et al. Refined mapping of the epilepsy susceptibility locus EJM1 on chromosome 6. Neurology 49, 842-847 (1997).
81. Pal, D. K. et al. BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. Am. J. Hum. Genet. 73, 261-270 (2003).
82. Lorenz, S. et al. Association of BRD2 polymorphisms with photoparoxysmal response. Neurosci. Lett. 400, 135-139 (2006).
83. Cavalleri, G. L. et al. A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy. Epilepsia 48, 706-712 (2007).
84. Helbig, I. et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat. Genet. 41, 160-162 (2009).
85. Cossette, P. et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 31, 184-189 (2002).
86. Suzuki, T. et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat. Genet. 36, 842-849 (2004).
87. Bai, D. et al. DNA variants in coding region of EFHC1: SNPs do not associate with juvenile. Myoclonic epilepsy. Epilepsia 50, 1184-1190 (2009).
88. Suls, A. et al. Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1. Ann. Neurol. 66, 415-419 (2009).
89. Vierck, E. et al. Polyspike and waves do not predict generalized tonic-clonic seizures in childhood absence epilepsy. J. Child Neurol. 25, 475-481 (2010).
90. Bouma, P. A., Westendorp, R. G., Van Dijk, J. G., Peters, A. C. & Brouwer, O. F. The outcome of absence epilepsy: a meta-analysis. Neurology 47, 802-808 (1996).
91. Levav, M. et al. Familial association of neuropsychological traits in patients with generalized and partial seizure disorders. J. Clin. Exp. Neuropsychol. 24, 311-326 (2002).
92. Battaglia, A. et al. The inv dup(15) syndrome: a clinically recognizable syndrome with altered behavior, mental retardation, and epilepsy. Neurology 48, 1081-1086 (1997).
93. Lippe, B. M. & Sparkes, R. S. Ring 14 chromosome: association with seizures. Am. J. Med. Genet. 9, 301-305 (1981).